Biotalys N.V [BTLS] vs Syneos Health [SYENS] Detailed Stock Comparison
Biotalys N.V
Euronext
Loading...
Syneos Health
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Biotalys N.V wins in 8 metrics, Syneos Health wins in 7 metrics, with 0 ties. Biotalys N.V appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Biotalys N.V | Syneos Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 377.86 | N/A |
| Price-to-Book Ratio | 8.40 | 1.19 | Syneos Health |
| Debt-to-Equity Ratio | 21.67 | 45.57 | Biotalys N.V |
| PEG Ratio | -11.25 | 5.04 | Biotalys N.V |
| EV/EBITDA | -10.95 | 7.70 | Biotalys N.V |
| Profit Margin (TTM) | 0.00% | -1.30% | Biotalys N.V |
| Operating Margin (TTM) | -589.49% | 10.86% | Syneos Health |
| EBITDA Margin (TTM) | N/A | 10.86% | N/A |
| Return on Equity | -75.33% | -1.20% | Syneos Health |
| Return on Assets (TTM) | -32.17% | 3.16% | Syneos Health |
| Free Cash Flow (TTM) | $-12.79M | $217.00M | Syneos Health |
| 1-Year Return | 45.83% | -14.86% | Biotalys N.V |
| Price-to-Sales Ratio (TTM) | -2,312.79 | 1.10 | Biotalys N.V |
| Enterprise Value | $152.87M | $9.15B | Syneos Health |
| EV/Revenue Ratio | -2,094.09 | 1.37 | Biotalys N.V |
| Gross Profit Margin (TTM) | N/A | 30.87% | N/A |
| Revenue per Share (TTM) | $0 | $64 | Syneos Health |
| Earnings per Share (Diluted) | $-0.40 | $-0.81 | Biotalys N.V |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Biotalys N.V vs Syneos Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Biotalys N.V | 2.25% | 2.02% | -6.19% | 1.11% | 27.45% | 30.00% |
| Syneos Health | 0.09% | -5.49% | -12.32% | 1.44% | 1.92% | -3.49% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Biotalys N.V | 45.83% | -17.57% | -35.00% | -35.00% | -35.00% | -35.00% |
| Syneos Health | -14.86% | -28.28% | -28.28% | -28.28% | -28.28% | -28.28% |
News Based Sentiment: Biotalys N.V vs Syneos Health
Biotalys N.V
News based Sentiment: MIXED
September presented a mixed picture for Biotalys, with increased financial losses offset by operational progress in patent protection and strategic partnerships. The ongoing delay in the EPA review of EVOCA™ remains a key risk, but the company's proactive cost management and expansion efforts suggest a commitment to long-term growth.
Syneos Health
News based Sentiment: NEUTRAL
September was a pivotal month marked by a major corporate event – the acquisition of Syneos Health and the subsequent emergence of Syensqo SA/NV. While the acquisition impacts former Syneos Health investors, Syensqo is actively building its profile through share buybacks, product innovation, and a positive analyst outlook, creating a neutral overall investment story.
Performance & Financial Health Analysis: Biotalys N.V vs Syneos Health
| Metric | BTLS | SYENS |
|---|---|---|
| Market Information | ||
| Market Cap | €170.71M | €7.38B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 26,309 | 136,607 |
| 90 Day Avg. Volume | 31,320 | 126,951 |
| Last Close | €4.55 | €67.78 |
| 52 Week Range | €2.51 - €5.50 | €53.70 - €84.85 |
| % from 52W High | -17.27% | -20.12% |
| All-Time High | €7.98 (Jun 28, 2021) | €109.90 (Dec 11, 2023) |
| % from All-Time High | -42.98% | -38.33% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.53% | -0.08% |
| Quarterly Earnings Growth | N/A | 0.72% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | -0.01% |
| Operating Margin (TTM) | -5.89% | 0.11% |
| Return on Equity (TTM) | -0.75% | -0.01% |
| Debt to Equity (MRQ) | 21.67 | 45.57 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €0.54 | €60.47 |
| Cash per Share (MRQ) | €0.48 | €12.85 |
| Operating Cash Flow (TTM) | €-12,216,000 | €749.00M |
| Levered Free Cash Flow (TTM) | €-4,318,875 | €451.50M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Biotalys N.V vs Syneos Health
| Metric | BTLS | SYENS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 377.86 |
| Forward P/E | -11.25 | 9.65 |
| PEG Ratio | -11.25 | 5.04 |
| Price to Sales (TTM) | -2,312.79 | 1.10 |
| Price to Book (MRQ) | 8.40 | 1.19 |
| Market Capitalization | ||
| Market Capitalization | €170.71M | €7.38B |
| Enterprise Value | €152.87M | €9.15B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | -2,094.09 | 1.37 |
| Enterprise to EBITDA | -10.95 | 7.70 |
| Risk & Other Metrics | ||
| Beta | N/A | N/A |
| Book Value per Share (MRQ) | €0.54 | €60.47 |
Financial Statements Comparison: Biotalys N.V vs Syneos Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BTLS | SYENS |
|---|---|---|
| Revenue/Sales | €0 | €1.68B |
| Cost of Goods Sold | N/A | €1.16B |
| Gross Profit | N/A | €514.00M |
| Research & Development | €3.47M | €78.00M |
| Operating Income (EBIT) | €-4.39M | €147.00M |
| EBITDA | €-2.99M | €306.00M |
| Pre-Tax Income | €-3.47M | €29.00M |
| Income Tax | €3,000 | €27.00M |
| Net Income (Profit) | €-3.47M | €2.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BTLS | SYENS |
|---|---|---|
| Cash & Equivalents | €22.64M | €579.00M |
| Total Current Assets | €26.24M | €3.28B |
| Total Current Liabilities | €4.77M | €2.07B |
| Long-Term Debt | €3.69M | €1.77B |
| Total Shareholders Equity | €27.61M | €7.27B |
| Retained Earnings | €-11.72M | €4.77B |
| Property, Plant & Equipment | €7.04M | €3.85B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BTLS | SYENS |
|---|---|---|
| Operating Cash Flow | €-4.09M | €40.00M |
| Capital Expenditures | €-93,000 | €-143.00M |
| Free Cash Flow | €-2.44M | €9.00M |
| Debt Repayment | N/A | €-166.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BTLS | SYENS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 26,309 | 136,607 |
| Average Daily Volume (90 Day) | 31,320 | 126,951 |
| Shares Outstanding | 37.46M | 103.45M |
| Float Shares | 13.15M | 69.83M |
| % Held by Insiders | 0.48% | 0.31% |
| % Held by Institutions | 0.22% | 0.28% |
Dividend Analysis & Yield Comparison: Biotalys N.V vs Syneos Health
| Metric | BTLS | SYENS |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |